Monoclonal antibodies were produced against two distinct Thai dengue-2 (DEN-2) virus strains isolated in 1980 from dengue haemorrhagic fever patients. Nine of 36 hybridomas produced monoclonal IgG antibodies which reacted in radioimmune precipitation assays with the NS1 non-structural protein (42000 mol. wt.) from DEN-2-infected C6/36 (Aedes albopictus) cells. The virus specificity of NS 1-reactive monoclonal antibodies was determined by indirect immunofluorescence assays using LLC-MK2 cells infected with either the Thai 1980 DEN-2 isolates, prototype DEN viruses (four serotypes), Japanese encephalitis (JE), Murray Valley encephalitis, West Nile, Wesselbron or Tembusu viruses. Eight of the monoclonal antibody preparations were DEN-2-serotype specific. One preparation defined a special serological relationship between DEN-2 and JE viruses. Four preparations had detectable complement fixation titres using Thai DEN-2 virus antigen. Six spatially unique epitopes were identified using competitive binding assays.
INTRODUCTION
Recently, antibodies directed against a flavivirus non-structural glycoprotein (NS1) have been shown to confer passive protection against yellow fever virus (Schlesinger et al., 1985; Gould et al., 1986) or dengue (DEN) virus challenge (J. J. Schlesinger, personal communication) in the mouse model. In the human patient, large amounts of anti-NS1 antibodies appear in convalescent sera (Falker et al., 1973; W. E. Brandt, personal communication) . Serotypespecific, dengue-complex, and flavivirus-group reactive antigenic determinants have been identified (Russell et al., 1970; Qureshi & Trent, 1973 ; Schlesinger et al., 1985) . However, there has been some speculation that this soluble complement-fixing antigen (SCF) may stimulate an anamnestic response during human secondary heterologous dengue infections, contributing to the pathogenesis of dengue shock syndrome.
With the advent of monoclonal antibody technology (K6hler & Milstein, 1976) , it is now possible to identify important epitopes on viral antigens. We have previously identified discrete antigenic regions on the E glycoprotein that participate in neutralization, haemagglutination, and infection enhancement (Henchal et al., 1985) . Moreover, these reagents have been used to identify serotype-specific and cross-reactive antigenic determinants . Here, we report the identification of unique epitopes on the NS1 non-structural protein.
METHODS

Cell cultures and virus propagation.
The propagation of dengue and other flaviviruses has been described before Henchal et al., 1982) . The dengue virus isolates used in this study, DS0-100 and D80-141, were originally isolated from dengue haemorrhagic fever patients treated at Bangkok Children's Hospital in March and April of 1980. The viruses were isolated in LLC-MK2 (monkey kidney) cells and passed several times in C6/36 (Aedes albopictus) cells. Maintenance medium for virus infections consisted of MEM with Earle's salts supplemented with 0"8~o bovine albumin. The virus isolates were passed no more than three times in BALB/c 0000-7472 suckling mice before the preparation of mouse brain antigen. Infected suckling mice were killed when moribund and frozen at -70 °C until required for immunizations.
Immunizations and the production of monoclonal antibody preparations. Immunizing antigen was prepared by grinding a 20~ (w/w) suspension of freshly thawed, infected BALB/c suckling mouse brains with phosphatebuffered saline pH 7.4, supplemented with 5~ bovine plasma albumin. Brain suspensions were clarified by centrifugation at 500 g for 5 min, and inoculated subcutaneously (0.5 ml) and intramuscularly (0.1 ml) on days 1 and 3, and intraperitoneally (0-5 ml) on days 21 and 28 into 6-week-old female BALB/c mice. Three days after the last immunization (day 31), splenocytes from immunized mice were fused to P3-X63-Ag8.653 myeloma cells (immunoglobulin non-producing; K6hler & Milstein, 1976) as described by Gentry et al. (1982) . Antibodyproducing cells were identified by testing cell culture supernatants by solid-phase radioimmunoassay (RIA). Selected hybridomas were subcloned using the limiting dilution method (Hengartner et al., 1978) until cell populations with homogeneous serological reactivities were obtained (at least two cycles of cloning). High-titred mouse ascitic fluids were produced in pristane-primed BALB/c mice (Kennett et aL, 1978) . Dengue-2 virus hyperimmune (DEN-2 HMAF) or normal mouse (NMAF) ascitic fluids were produced using the method described by Brandt et al. (1967) . Mouse ascitic fluids were screened for reactions with uninfected cell antigens and titrated against dengue virus antigens using RIA. Monoclonal antibody preparations which were unreactive in haemagglutination inhibition and plaque reduction neutralization assays were selected for further study.
Serological assays. The virus plaque reduction neutralization (PRNT), haemagglutination inhibition (HI), and indirect immunofluorescence (IF) assays were performed as described previously (Russell et al., 1967; Clarke & Casals, 1958; Henchal et al., 1982) . The solid phase RIA was performed as described previously (ZoUinger et al., 1976; except that all antibody adsorptions were performed for only 2 h at room temperature and the plates were washed with phosphate-buffered saline (PBS) containing 0.05~ Tween 20. RIA antigen was prepared by homogenizing infected or uninfected C6/36 cells in 0.5 ~ Triton X-100, 0.05 M-NaCI, 0.02 M-Tris-HC1 pH 8.0, 5 ~tg/ml PMSF. The concentration of clarified antigen preparations was optimized using DEN-2 HMAF . RIA antigen from uninfected cells was diluted 1:4 before adsorption to the microtitre plates. The Laboratory Branch Complement Fixation Test (Centers for Disease Control, 1981) adapted for microtitre plates was performed using virus-infected (D80-100) sucrose-and acetone-extracted suckling mouse brain antigen (Clarke & Casals, 1958) .
Radioimmunoprecipitation assays (RIPA). These were performed using the method described by Smith & Wright (1985) . C6/36 cells in 25 cm 2 flasks were infected with D80-100 virus at approximately 1 p.f.u, per cell. Maintenance medium containing one-tenth the normal concentration of methionine and supplemented with actinomycin D at 3 ~tg/ml was added to the flasks after 120 h post-infection. After an additional 3 h of incubation, [35S]methionine (80 ~Ci/ml) was added. The cell monolayers were disrupted by scraping, and cell pellets were obtained by low speed centrifugation. Radioactive antigens were solubilized using the method described by Wechsler et al. (1979) , by resuspending the cell pellets in RIPA buffer (10 mM-Tris-HCl pH 7.4, 150 mM-NaC1, 1.0 ~ Triton X-100, 0.5 ~ sodium deoxycholate, 0.1 ~ SDS and 5 ~tg/ml PMSF) and passing the suspension through a 26-gauge needle three times. Clarified antigen preparations were reacted with monoclonal antibody ascitic fluids (MAF) as described by Wright et aL (1981) . Briefly, antibody-antigen complexes formed after an overnight incubation at 4 °C were collected with Protein A-coated Sepharose CL-4B beads (Pharmacia). The beads were washed five times with RIPA buffer containing detergents at half strength. Precipitated antigens eluted in 35 ~tl of 3~ SDS were evaluated by electrophoresis on 12~ polyacrylamide gels using the discontinuous buffer system (Laemmli, 1970) . Non-radioactive protein mol. wt. markers were used in wells adjacent to the test wells. Gels were fixed, stained, processed for fluorography and exposed to Fuji R-3 X-ray film (Bonner & Laskey, 1974) . X-ray films were developed according to the manufacturer's directions.
Competitive binding assays. The relative position of each monoclonal antibody site was determined using competitive binding assays described by Henchal et al. (1985) . Briefly, the gamma globulin fraction of each MAF preparation was prepared by ammonium sulphate precipitation followed by de-salting column chromatography on Sephadex G-25 using PBS. Approximately 100 ~tg of protein in 40 ~tl was radiolabelled with 1251 using the chloramine-T method (Greenwood et al., 1963) . Quadruplicate aliquots of unlabelled ascitic fluids at a 1 : 100 dilution were incubated for 2 h at room temperature with D80-100 RIA antigen adsorbed to flexible 96-well plates. After washing of the plates with PBS-Tween 20, radioactive antibody preparations (240 000 c.p.m, per well) were incubated in the wells for 2 h at room temperature. The plates were washed and processed in the usual manner. Mean antibody binding in the presence of unlabelled monoclonal antibodies was compared to that in the presence of NMAF using Student's t-test for two independent means.
RESULTS
Determination of the antigen specificity of the antibodies
Thirty-six stable hybridomas were produced using selected Thai dengue-2 virus isolates from 1980. MAF were produced with each clone and the preparations were evaluated using PRNT, < 10 < I0 8 7.1 20-1/1 < 10 < 10 <8 7.0 27-12/4 < 10 < 10 8 7.7 34-23 < 10 < 10 <8 7.0 40-21/9 < 10 < 10 <8 6.9 47-10/10 < 10 < 10 <8 7.1 63-15 < 10 < 10 8 6.9 68-5/16 < 10 < 10 2048 6.7 101-4/7 < 10 < 10 <8 7.8 * PRNT results are reported as the reciprocal dilution of the 50~ neutralization point. All other results are the reciprocal of the endpoint dilution. The reciprocal of the highest serum dilution that resulted in binding equal to 2-1 times the c.p.m, bound by a similar dilution of NMAF was taken as the RIA endpoint titre.
HI, c o m p l e m e n t fixation (CF) and R I A assays. N i n e preparations failed to react in either the P R N T or H I assay, and only four (16-25/3, 27-12/4, 63-15 and 68-5/16) had detectable C F titres against mouse brain-derived D E N-2 (D80-100) antigen (Table 1 ). All had R I A endpoint titres in the range 10 6.7 to 107"8 In order to determine the antigen specificity o f these unique antibodies, each preparation was reacted with [3SS]methionine-labelled D80-100 antigens in a RIPA. The reactions of DEN-2 HMAF, NMAF and nine monoclonal antibodies are shown in Fig. 1 . DEN-2 HMAF precipitated approximately 11 polypeptides; the major proteins were of tool. wt. 72000 (72K), 62K, 55K, 42K, 22K, 20K and 15K. Weaker reactions were seen with proteins of mol. wt. between 32K and 25K, and 18K. Nine of the preparations reacted with a 42K protein from dengue virus-infected cells, which has a mol. wt. consistent with that of the NSI protein (Rice et al., 1985; Smith & Wright, 1985) . Two preparations, 27-12/4 and 47-10/10, reacted additionally with a 22K protein. Other proteins were not reproducibly precipitated, or were also found in uninfected cell preparations (data not shown).
Virus specificity
In order to define the virus specificity of the monoclonal antibodies for different flaviviruses, each antibody preparation was tested in indirect IF assays against LLC-MK2 cells infected with prototype dengue virus serotypes, Japanese encephalitis, Murray Valley encephalitis, West Nile, Wesselbron and Tembusu viruses. As can be seen Table 2 , eight of the monoclonal antibodies were dengue-2 virus-specific, having IF titres in the range 40 to 5120. One monoclonal antibody, 27-12/4, demonstrated unique specificity for dengue-2 and Japanese encephalitis viruses with IF titres of 5120 and 20480, respectively.
Competitive binding assays
The relative positions of antibody binding sites were determined by measuring the amount of radiolabelled antibody bound in the presence of unlabelled monoclonal antibodies or NMAF. Differences in mean binding were then evaluated using standard statistical tests. Epitopes on the dengue-2 virus NS1 protein The relationship among the binding groups was determined by comparing the reactions of group members to other individual monoclonal antibody preparations from other groups. As depicted graphically in Fig. 2 , these binding groups formed a large antigenic complex or domain of contiguous binding sites. However, some anomalous, non-reciprocal blocking patterns between groups or individual antibody preparations existed. The binding of radiolabelled 47-10/10 and 27-12/4 antibodies was not reciprocally blocked by 68-5/16, and by 63-15 or 68-5/16, respectively.
DISCUSSION
Rational identification of specific polypeptides for use in future vaccine preparations may greatly benefit from a thorough analysis of the structure or topology of specific antigens. Competitive binding assays provide a method for determining the degree of relative spatial overlap between individual antibody binding sites (Yewdell & Gerhard, 1981; Heinz, 1986) . Monoclonal antibody preparations which have virtually identical serological reactivities have been differentiated using topological mapping in this fashion (Heinz et al., 1984; KimuraKuroda & Yasui, 1983; Roehrig et al., 1983; Schlesinger et al., 1984; Henchal et al., 1985; Heinz, 1986) .
In this study we describe nine monoclonal antibodies which reacted with the dengue-2 virus NS1 (42K) non-structural protein. Using competitive binding assays these preparations were arranged into approximately six groups which probably represent distinct antigenic epitopes. Eight of the nine antibodies were dengue virus serotype-specific by indirect IF, and bind to a large serotype-specific antigenic domain. These results confirm results reported previously by others using SCF antigen (Russell et al., 1970; Qureshi & Trent, 1973) . One monoclonal antibody preparation, 27-12/4, reacted only with dengue-2 and Japanese encephalitis viruses. While cross-reactive determinants have been identified previously on the NSI protein (Russell et al., 1970; Schlesinger et al., 1985) , this is the first description of an epitope defining a special serological relationship between these viruses. The close proximity of this antibody binding site to a large serotype-specific domain is similar to previous findings (Henchal et al., 1985) in which cross-reactive epitopes regularly alternated with serotype-specific epitopes on the dengue-2 virus E glycoprotein (Henchal et al., 1985) .
Anomalous one-way blocking might result from any of the following conditions: displacement of bound antibody by a more avid species, positional effects in which antibody binding on the surface of the antigen blocks binding to a site deeper in the structure, or conformational changes in which binding to positionally distant epitopes affect binding sites elsewhere in the polypeptide antigen. However, in this study, the failure of some antibodies reciprocally to block the binding of radiolabelled 27-12/4 and 47-10/10 could be due to the absence of blocking epitopes on the lesser 22K polypeptide. Additional studies are required to confirm the identity and structure of this antigen.
Further intensive study of the antigenic structure of immunodominant epitopes will become increasingly important as we attempt to construct immunogenic, protective polypeptides from linear sequence information.
